RBC Bioscience

RBC Bioscience EBITDA per Share

The EBITDA per Share of RBC Bioscience (6848.TWO) as of Oct 5, 2026 is 2.72 TWD. In the previous year, EBITDA per Share was 1.37 TWD — a change of 97.97% (higher).

EBITDA per Share

2.72TWD

YoY

97.97%

Last updated:

EBITDA per Share of RBC Bioscience is 2026 2.72 TWD. EBITDA per Share of RBC Bioscience was 2025 1.37 TWD. It decreases by 97.97% higher compared to the previous year.

The RBC Bioscience EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.99 TWD
Jan 1, 2019
2.37 TWD
Jan 1, 2020
15.67 TWD
Jan 1, 2021
3.95 TWD
Jan 1, 2022
0.60 TWD
Jan 1, 2023
1.37 TWD
Jan 1, 2024
2.72 TWD
The RBC Bioscience EBITDA per Share history
YEAREBITDA per ShareYoY
2.72TWD+97.97%
1.37TWD+129.94%
0.60TWD-84.89%
3.95TWD-74.77%
15.67TWD+560.85%
2.37TWD+139.83%
0.99TWD—
Access this data via the Eulerpool API
Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

EBITDA per Share of RBC Bioscience is 2.72 TWD in 2026.

EBITDA per Share of RBC Bioscience changed from 1.37 TWD to 2.72 TWD, representing a 97.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — RBC Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — RBC Bioscience